BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21464326)

  • 1. Differential transformation capacity of Src family kinases during the initiation of prostate cancer.
    Cai H; Smith DA; Memarzadeh S; Lowell CA; Cooper JA; Witte ON
    Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6579-84. PubMed ID: 21464326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.
    Gelman IH; Peresie J; Eng KH; Foster BA
    Mol Cancer Res; 2014 Oct; 12(10):1470-9. PubMed ID: 25053806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
    Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets.
    Canobbio I; Cipolla L; Guidetti GF; Manganaro D; Visconte C; Kim S; Okigaki M; Falasca M; Kunapuli SP; Torti M
    Biochem J; 2015 Jul; 469(2):199-210. PubMed ID: 25967238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src signaling pathways in prostate cancer.
    Varkaris A; Katsiampoura AD; Araujo JC; Gallick GE; Corn PG
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):595-606. PubMed ID: 24522479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.
    Sato I; Obata Y; Kasahara K; Nakayama Y; Fukumoto Y; Yamasaki T; Yokoyama KK; Saito T; Yamaguchi N
    J Cell Sci; 2009 Apr; 122(Pt 7):965-75. PubMed ID: 19258394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress.
    Dorotea D; Jiang S; Pak ES; Son JB; Choi HG; Ahn SM; Ha H
    Exp Mol Med; 2022 Aug; 54(8):1086-1097. PubMed ID: 35918533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration.
    Yadav V; Denning MF
    Mol Carcinog; 2011 May; 50(5):346-52. PubMed ID: 21480388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The residue at position 5 of the N-terminal region of Src and Fyn modulates their myristoylation, palmitoylation, and membrane interactions.
    Gottlieb-Abraham E; Gutman O; Pai GM; Rubio I; Henis YI
    Mol Biol Cell; 2016 Dec; 27(24):3926-3936. PubMed ID: 27733622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.
    Liu A; Gong P; Hyun SW; Wang KZ; Cates EA; Perkins D; Bannerman DD; Puché AC; Toshchakov VY; Fang S; Auron PE; Vogel SN; Goldblum SE
    J Biol Chem; 2012 May; 287(20):16132-45. PubMed ID: 22447928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src family kinases are required for integrin but not PDGFR signal transduction.
    Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
    EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Src in prostate cancer.
    Fizazi K
    Ann Oncol; 2007 Nov; 18(11):1765-73. PubMed ID: 17426060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and activation of Src family kinases in primary megakaryocytes.
    Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
    Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
    Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
    Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for N-Cadherin linked c-Src and fyn kinases in lens development.
    Leonard M; Zhang L; Bleaken BM; Menko AS
    Dev Dyn; 2013 May; 242(5):469-84. PubMed ID: 23361870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
    Li W; Marshall C; Mei L; Gelfand J; Seykora JT
    J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses.
    Dallari S; Macal M; Loureiro ME; Jo Y; Swanson L; Hesser C; Ghosh P; Zuniga EI
    Nat Commun; 2017 Apr; 8():14830. PubMed ID: 28368000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src family kinases differentially influence glioma growth and motility.
    Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
    Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.